Aman Goyal, Sunil Kumar, Dr.Poonam Verma


BACKGROUND: Melasma is a common acquired hyperpigmentary disorder characterized by irregular light or dark
brown macules in sunexposed areas of skin. It is a consequence of specific hyperfunctional melanocytes that cause
excessive melanin deposition in skin.
AIMS – Our present research aims to study the clinico-epidemological profile and precipitating and aggravating factors
of melasma.
MATERIAL AND METHODS – Three hundred patients of melasma attending out-patient department of dermatology
were included in the study.
RESULTS – The mean age of melasma patient in our study was 32.3 years with the female to male ratio of 3:1. The mean
age of onset was 26.87 years. The mean duration of disease in present study was 6.23 years. Centrofacial melasma and
epidermal type were the most common pattern seen. Familial predisposition, pregnancy, sun-exposure were the most
common triggering factors observed.
CONCLUSION – The study indicates was melasma has a wide variation in its clinico-epidemological profile and many
factors are involved in its etiopathogenesis.

Full Text:



Kauh YC, Zachian TF. Melasma. Adv Exp Med Biol 1999;455:491-9.

Grimes P, Kelly AP, Torok H, et al. Community-based trial of a triple-combination agent for the treatment of facial melasma. Cutis 2006;77:177-84.

Sanchez NP, Pathak MA, Sato S. Melasma: A clinical, light microscopic, ultrastructural and immunofluorescene study. J Am Acad Dermatol 1981;4:698-710.

Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol 1995;131:1453-7.

Pandya AG, Guevara IL. Disoreders of hyperpigmentation. Dermatol Clin 2000;18:91-8.

Lufti RJ, Fridmanis M, Misrunas AL. Association of melasma with thyroid autoimmunity and other thyroid abnormalities and their relationship to the origin of melasma. J Clin Endocrinol Metab 1985;61:28-31.

Cayce K.A, McMichael A.J., Feldman S.R.Hyperpigmentation:An overview of the common afflictions. Dermatol Nursing 2004;16:401-16.

Pichardo R, Vallejos Q, Feldman SR. The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol 2009;48:22-6.

Taylor SC. Epidemiology of skin disease in ethnic populations. Dermatol Clin 2003;21:601-7.

Werlinger KD, Guevara IL, Gonzalez CM. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol 2007;143:424-5.

Arenas R. Melasma. In : Arenas R, ed. Dermatologia:Atlas, Diagnostico Y Tratamiento. Interamericana – McGraw-Hill, Mexico City, Mexico,1996,96.

Karen JK, Pomeranz MK. Skin changes and diseases in pregnancy. In : Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editors. Fitzpatrick's dermatology in general medicine. 7th ed. McGraw Hill, New York; 2008.p.955-9.

Wong RC, Ellis, CN. Physiologic changes in pregnancy. J Am Acad Dermatol 1984;10:929-40.

Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol 2006;45:285-88.

Muzaffar F, Hussain I, Haroon TS. Physiologic skin changes during pregnancy. Int J Dermatol 1998;37:429-31.

Iraji F.Studying skin changes in 235 pregnant women: Isfathan Med Univ J 1998;54:13-7.

Hann SL, Im S, Chung WS, Kim do Y. Pigmentary disorders in the South East. Dermatol Clin.2007;25:431-8.

Kimbrough Green CK, Griffiths CE, Finkel LJ, Hamilton TA, Bulengo Ramsby SM, Ellis CN, et al. Topical retinoic acid (Tretinoin) for melasma in black patients; a vehicle controlled clinical trial. Arch Dermatol 1994;130:727-33.

Sarkar R, Jain RK, Puri P. Melasma in Indian males. Dermatol Surg 2003;29:204.

Goh CL. Dlova CN. A retrospective study on the clinical presentation and treatment outcome of melasma in a tertiary dermatological referral centre in Singapore. Singapore Med J 1999;40(7):455-8.

Moin A, Jabery Z, Fallah N. Prevalence and awareness of melasma during pregnancy. Int J Dermatol. 2006 Mar;45(3):285-8.

Ortonne JP, Arellano I, Berneburg M, Cestari T, Chan H, Grimes PA, et al. Global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J Eur Acad Dermatol Venereol 2009;23(11): 1254-62.

Guinot C, Cheffai S, Latreille J, Dhaoui MA, Youssef S, Jaber K, et al. Aggravating factors for melasma: a prospective study in 197 Tunisian patients. J Eur Acad Dermatol Venereol. 2010 Sep;24(9):1060-9.

Achar A, Rathi SK. Melasma : a clinico-epidemiological study of 312 cases. Indian J Dermatol 2011;56(4):380-2.


  • There are currently no refbacks.